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It has been known for some time that plants and insects use RNA interference (RNAi) as nucleic acid-based immunity against viral infections.
However, it was unknown whether mammalian cells employ the RNA interference pathway as an antiviral mechanism as well. Over the past years,
it has become clear that a variety of viruses, first in plants but recently in insect and mammalian viruses as well, encode suppressors of the RNAi
pathway arguing for an antiviral role of this machinery. More recent findings have revealed that certain viruses encode their own microRNAs or
microRNA-like RNA molecules, which are processed by the mammalian RNAi machinery. Furthermore, host-encoded microRNAs have been
shown to both silence and enhance intracellular levels of viral RNAs. These findings argue that interactions between the RNAi pathway and viral
genomes can profoundly affect the outcomes of the viral life cycles and contribute to the pathogenic signatures of the infectious agents.
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Effects of small RNAs on gene expression were first
observed in 1990, when plant biologists attempted to make
purple petunias more vividly purple by overexpressing the
purple pigment-synthesizing enzyme, chalcone synthase. Sur-
prisingly, the transgene-carrying plants turned white, indicating
that the endogenous gene and the transgene were co-0042-6822/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2005.09.034
* Corresponding author. Fax: +1 650 498 7147.
E-mail address: psarnow@stanford.edu (P. Sarnow).suppressed (Napoli et al., 1990; van der Krol et al., 1990).
Subsequently, this posttranscriptional gene silencing (PTGS)
was attributed to the generation and action of small, double-
stranded RNAs (Hamilton and Baulcombe, 1999). Since then,
gene silencing by small duplex RNA molecules has been
termed ‘‘RNA interference’’ or RNAi (Rocheleau et al., 1997).
Biochemical analysis of the small interfering RNAs (siRNAs)
revealed that they were processed from larger double-stranded
precursors (Hammond et al., 2000; Zamore et al., 2000) by an
ATP-dependent RNAse III-like nuclease termed Dicer (Bern-
stein et al., 2001; Nykanen et al., 2001). In mammalian cells,6) 151 – 157
www.e
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nucleotides in length, contain a monophosphate at their 5V ends
and two unpaired nucleotides at their 3V ends (Elbashir et al.,
2001a, 2001b). After processing by Dicer, the siRNAs are then
transferred to the RNA-induced silencing complex (RISC)
which guides the siRNAs to their target RNAs (Hammond et
al., 2000; Zamore et al., 2000). Perfect base complementarity
between an siRNA and its target mRNA usually results in the
degradation of the mRNA. Today, tailored duplex RNAs are
widely used to reduce the expression of target genes in
eukaryotic cells.
In parallel, it was observed that double-stranded RNA
molecules could specifically interfere with gene expression in
the nematode C. elegans (Fire et al., 1998). Subsequent genetic
screens identified small temporal RNA (stRNA) molecules that
were similar in size to the siRNAs. In contrast to the siRNAs,
however, these molecules were single-stranded and exhibited
pairing with genetically defined target mRNA sequences which
were only partially complementary to the stRNA (Bartel,
2004). Specifically, stRNAs lin-4 and let-7 were found to
interact with the 3V noncoding regions of target lin-14 and lin-
41 mRNAs, respectively, causing reduced accumulation of the
mRNA-encoded proteins. These findings prompted severalFig. 1. Interactions of viruses with the RNA interference machinery. (1) Liver-spec
promotes viral replication. (2) MiR-32 binds to PFV-1 RNA and lowers viral RN
produces large amounts of VA RNAs, that are transported via Exportin 5 (Exp5), pr
entire RNAi pathway. (4) Viral dsRNA induces the production of viral siRNAs by D
NSs counteract this defense. (5) Viruses such as EBV, KHSV and SV40 encode t
expression. See text for details.investigators to search for stRNA-like molecules in a variety of
organisms, leading to the discovery of hundreds of highly
conserved RNA molecules with stRNA-like structural proper-
ties (Lewis et al., 2003). These small RNAs are now known as
microRNAs (miRNAs). They are processed from hairpin-like
precursor molecules by Dicer and are present in virtually every
tissue of every animal investigated (Lagos-Quintana et al.,
2002). Thus, the RNAi pathway guides two distinct RNA
species, double-stranded siRNAs and single-stranded micro-
RNAs, to the cytoplasmic RISC complex which presents them
to their target molecules.
Biogenesis and target recognition of microRNAs
In general, microRNAs are transcribed by polymerase II as
large precursor RNAs which are processed by the nuclear
ribonuclease III-like enzyme Drosha aided by protein DGCR8
(Tomari and Zamore, 2005). The processed pre-microRNA
molecules, approximately 70 nucleotides in length, are then
exported via the Exportin 5 receptor to the cytoplasm (Yi et al.,
2003) where they are further processed by Dicer, followed by
asymmetric assembly of one of the microRNA strands into the
RISC complex (Tomari et al., 2005) (Fig. 1).ific microRNA miR-122 binds to the 5V noncoding region of HCV RNA and
A amounts. The viral protein Tas inhibits microRNA activity. (3) Adenovirus
ocessed by Dicer and incorporated into RISC, resulting in the saturation of the
icer, resulting in the degradation of viral RNAs. HIV-1 Tat, NoV B2 and LACV
heir own microRNAs that are used to modulate host gene expression or viral
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findings have shown that the 5V 7–8 nucleotides of a microRNA
engages in perfect Watson–Crick base pairing with its target
mRNA, leading to the formation of an A-form RNA duplex
(Lewis et al., 2005). While there has been wide spread
speculation that microRNAs inhibit the translation of mRNAs
in microRNA/mRNA complexes (Doench and Sharp, 2004)
(Olsen and Ambros, 1999; Pillai et al., 2005), very recent data
have shown that interaction of microRNAs with natural target
mRNAs can also lead to mRNA degradation (Bagga et al.,
2005). Therefore, it is likely that the microRNP or RISC
complex can induce degradation, translational repression, or
both, of target mRNAs. The choice of mechanism may be
dependent on the number of microRNA-binding sites and the
degree of base complementarity between the microRNA and the
target mRNA.
Plant and insect viruses encode suppressors of RNA
silencing
Interactions of viruses with the RNAi machinery were first
noted during infections of plants and insects. Specifically, it was
observed that the infected hosts used RNA silencing as a nucleic
acid-based immunity to destroy viral RNA. To counteract this
defense, several viruses have developed a wide variety of
suppressors of RNA silencing (SRS). Two well-studied exam-
ples of plant SRS proteins are tombusviral P19 and potyviral
HcPro proteins. Whereas P19 specifically binds siRNAs,
inhibiting their incorporation into the RISC complex (Lakatos
et al., 2004), HcPro prevents themicroRNA-directed cleavage of
target RNAs and is believed to function at a step that involves
Dicer and RISC (Kasschau et al., 2003). Detailed descriptions of
plant SRS proteins can be found in several excellent publications
(Roth et al., 2004; Silhavy and Burgyan, 2004; Vance and
Vaucheret, 2001; Voinnet, 2001, 2005). Curiously, several plant
viral SRS proteins from a wide range of viruses can enhance the
replication of heterologous viruses, suggesting that common
components of the RNAi machinery are targeted by the SRS
proteins (Dunoyer et al., 2004; Kasschau et al., 2003; Pruss et al.,
1997).
Inhibition of the RNA silencing pathway in invertebrate
cells by animal viruses
The next milestone in the interaction of the RNA silencing
machinery and viruses was set by Ding and colleagues with the
discovery that Flock house virus (FHV) infection of Drosoph-
ila cells first induced and subsequently suppressed a host-
induced antiviral RNA silencing response (Li et al., 2002).
Subsequently, the viral B2 protein was found to inhibit RNA
silencing in both insect cells and in transgenic plants,
demonstrating that the SRS proteins are functioning across
kingdoms (Li et al., 2002, 2004). Nodamura virus (NoV),
which can infect both insects and mammals, encodes a B2
protein that is very similar to the FHV B2 protein. Recently, it
was found that the NoV B2 protein can inhibit the mammalian
RNAi pathway by binding to pre-Dicer substrates and maturesiRNA molecules, resulting in interference with Dicer-directed
cleavage and, probably, incorporation of siRNAs into the RISC
complex (Sullivan and Ganem, 2005) (Fig. 1). Similarly, the
tripartite negative-stranded La Crosse virus, a bunyavirus
which can infect both insect and mammalian hosts, was found
to encode a nonstructural protein, NSs, which displays RNA
silencing suppressor activity in human 293T cells (Soldan et
al., 2005) (Fig. 1). Another bunyavirus, Tomato spotted wilt
virus, subsequently was found to encode an NSs protein with
similar activity (Bucher et al., 2003; Takeda et al., 2002). It is
as yet unknown whether either bunyaviral NSs protein
functions as an SRS in insect cells. Overall, these findings
demonstrate that viruses can interfere with the RNAi pathway
by encoding suppressor proteins that act across kingdoms. Due
to the wide host range of the viruses and the conservation of the
RNAi machinery, however, it is not clear in some cases which
host the virus has evolved to combat.
Inhibition of the RNA silencing pathway in mammalian
cells by animal viruses
In contrast to the examples from plant and invertebrate
viruses, which encode SRS proteins to inhibit the degradation of
viral RNA by the RNAi pathway (Voinnet et al., 1999), it was
thought that mammalian viruses might not need to interfere with
the RNAi pathway because of the ubiquity and effectiveness of
the interferon system which responds to the accumulation of
viral double-stranded RNAs by inducing the synthesis of a large
group of genes which exert inhibitory effects on viral gene
expression (reviewed in (Gale et al., 2000; Katze et al., 2002).
For example, protein kinase PKR, when activated by cytoplas-
mic double-stranded RNAs, leads to the rapid phosphorylation
of eukaryotic initiation factor eIF2 and subsequent inhibition of
both host and viral mRNA translation (reviewed in Jagus et al.,
1999; Kaufman, 1999). However, with the discovery by Elbashir
and colleagues that the expression of small siRNAs does not
induce the mammalian interferon machinery (Elbashir et al.,
2001a, 2001b), the question arose whether mammalian viruses
could be targeted by the generation of small siRNAs by the
RNAi machinery in mammalian cells, and whether viruses
would have means to avoid such an attack.
The first answers to these questions came from studies with
adenoviruses. It has been known for a long time that the
adenoviral genome encodes VA (virus-associated) RNAs
which are expressed by host RNA polymerase III. VA RNAs
are highly structured RNAs, approximately 160 nucleotides in
length, which can accumulate to 108 molecules per infected cell
(Mathews and Shenk, 1991). VA1 RNA was shown to bind to
PKR, thereby inhibiting its activation by viral double-stranded
RNAs and thus allowing translation of viral mRNAs (reviewed
in (Mathews and Shenk, 1991). Subsequently, it was discov-
ered that VA1 RNAs are exported from the nucleus to the
cytoplasm by the Exportin 5 factor (Gwizdek et al., 2003), the
same export receptor that exports pre-microRNAs (Bohnsack et
al., 2004; Lund et al., 2004; Yi et al., 2003) (Fig. 1). Recent
data have shown that VA1 RNAs can inhibit nuclear-
cytoplasmic translocation of pre-microRNAs by competing
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2004). In addition, it has been reported that both VA1 and VA2
RNAs competitively suppress DICER activity (Fig. 1). DICER
can process bound VA RNAs leading to the generation of
siRNAs that are associated with RISC complexes during lytic
infection (Andersson et al., 2005). Natural cellular or viral
targets for VA-siRNAs are yet unknown. It is therefore likely
that VA RNAs aid in viral subversion of infected hosts by
preventing activation of PKR as well as by inhibiting several
steps of the host RNAi pathway (Fig. 1).
These findings raised the question whether other virus-
encoded proteins that inactivate PKR also inhibit the host
RNAi pathway. Indeed, influenza virus NS1 and vaccinia virus
E3L proteins, which are both inhibitors of PKR (Garcia-Sastre,
2002), were the first discovered proteins encoded by mamma-
lian viruses shown to be active against the invertebrate RNAi
machinery (Li et al., 2004). The ability of these proteins to
suppress the RNAi pathway was shown in Drosophila cells
and is believed to be mediated by the dsRNA-binding domains
located in both proteins (Li et al., 2004). Because a functional
PKR pathway has not been detected in insect cells, the
inhibitory effects of NS1 and E3L in Drosophila cells are
most likely due to inhibition of the RNAi pathway. Whether
these two viral proteins suppress RNA silencing in infected
mammalian cells remains to be shown.
Identification of virus-encoded microRNAs
Studies with VA RNAs have raised the question whether
siRNAs generated from viral sequences can function as
microRNAs, modulating either viral or host cell gene
expression. To address this possibility, Pfeffer et al. (2004)
isolated total small RNAs from a Burkitt’s lymphoma cell line
that was latently infected with Epstein–Barr virus (EBV) (Fig.
1). Cloning and sequencing of these RNA species revealed that
approximately 4% of the recovered cDNAs were viral
sequences. Five of these RNAs were encoded in two regions
of the EBV genome, and were predicted to reside in the stem–
loop structures characteristic of microRNA precursor genes.
One of these viral microRNA species, miR-BART2, was
predicted to be perfectly complementary to the viral DNA
polymerase BALF5 gene. If functional, targeted mRNA
cleavage should result in the appearance of a processed 3.7
kb RNA species of the full-length 5.0 kb BALF5 mRNA,
generated by a miR-BART2-induced siRNA-type mechanism
(Pfeffer et al., 2004). Indeed, a 3.7-kb BALF5 mRNA species
can be detected in EBV-replicating cells (Furnari et al., 1993).
Several cellular targets of EBV-encoded microRNAs have been
predicted, but experimental verification of any functional
interaction has not yet been reported. Using improved
computational algorithms, microRNA-encoding genes were
subsequently predicted and their expression biochemically
verified in other members of the herpesvirus family (Fig. 1).
Specifically, human cytomegalovirus expresses at least 5
microRNAs (Grey et al., 2005; Pfeffer et al., 2005), which
are generally expressed at early times during viral infection
(Grey et al., 2005). In addition, Kaposi’s sarcoma-associatedherpesvirus (KSHV), human herpesvirus 8, expresses 11
microRNAs in latently infected cells (Cai et al., 2005; Pfeffer
et al., 2005; Samols et al., 2005). Curiously, 10 of the 11
KSHV microRNAs are predicted to be expressed from a single
primary microRNA transcript, which resides in a single intron.
While cellular targets for the KSHV microRNAs might be
predicted to be down-regulated during KSHV infection (Cai et
al., 2005), no genetic or biochemical evidence for KSHV
microRNA-target mRNA interactions has been reported yet.
Interestingly, the algorithms that predicted verifiable micro-
RNAs from herpes virus genomes predicted no microRNAs
encoded in, for example, the human immunodeficiency virus
(HIV) genome (Pfeffer et al., 2005). However, two recent
studies have reported that the host RNAi pathway can generate
viral siRNAs from env- and nef-encoding regions of the HIV
genome (Bennasser et al., 2004, 2005; Omoto and Fujii, 2005;
Omoto et al., 2004); intriguingly, the HIV Tat protein seems to
function as an SRS by altering the ability of Dicer to process
helical precursor RNAs into siRNAs (Bennasser et al., 2005). It
is possible that the generation of HIV-derived microRNAs is
dependent on the experimental system or the intracellular
concentrations of substrate RNAs. As yet, it is unknown
whether HIV-derived microRNAs or siRNAs are produced
during natural HIV infections.
The only virus-encoded microRNAs known to have func-
tional roles in the infectious cycle are microRNAs processed
from late viral transcripts in simian virus 40 (SV40)-infected
cells (Sullivan et al., 2005). Similarly to the herpesvirus studies,
Sullivan and colleagues used a computer-aided algorithm to
identify microRNAs encoded in the SV40 genome. Subsequent
Northern blot analysis verified the presence of microRNAs
processed from late SV40 transcripts (Fig. 1). The SV40
microRNAs were excised from both arms of a predicted pre-
microRNA hairpin structure and found both to be perfectly
complementary to early SV40 transcripts that encode both the
large ‘‘T’’ and small ‘‘t’’ SV40 tumor antigens. As predicted,
these target mRNAs were cleaved in wildtype SV40 infections,
but not in infections with mutant SV40 that contained mutations
to disrupt the predicted pre-microRNA hairpin structure. As a
result, the abundance of both large and small tumor antigens was
reduced at late times in wildtype, but not in mutant SV40-
infected cells. Surprisingly, downregulation of the tumor
antigens did not affect the final viral yield in cultured cells,
pointing to a role for SV40 microRNAs in a step that did not
include viral gene expression. Indeed, it was found that SV40
microRNA-mediated downregulation of the tumor antigens
resulted in reduced susceptibility to and activation of responsive
cytotoxic T lymphocytes (Sullivan et al., 2005). Thus, SV40
may subvert the host RNAi machinery to process virus-encoded
microRNAs whose activities lead to virus escape from antiviral
attacks exerted by the host immune response.
Subversion of a tissue-specific microRNA to aid in viral
gene expression
Very recently, an example emerged whereby a viral genome
subverts a host microRNA to increase viral gene expression.
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specific microRNA, miR-122, upregulates the expression of
the hepatitis C virus (HCV) genome in cultured liver cells;
sequestration of miR-122 by methylated oligonucleotides
resulted in loss of HCV RNA (Jopling et al., 2005) (Fig. 1).
Subsequently, the binding site for miR-122 was mapped to the
very 5V end of the viral genome. This was curious, because no
animal microRNAs (Lewis et al., 2005), and only two plant
microRNAs (Sunkar and Zhu, 2004), have been shown to
interact with the 5V noncoding regions of their target mRNAs.
Mutations in the miR-122 binding site at the 5V end of the HCV
genome abolished viral RNA accumulation, which could,
however, be restored by ectopic expression of miR-122
molecules that contained mutations to restore predicted base
complementarity. Studies with replication-defective genomes
revealed that miR-122–HCV interactions affected primarily
viral RNA replication and not mRNA translation or RNA
turnover. These findings provide an unprecedented example of
a virus exploiting a cellular microRNA for its own purposes
(Jopling et al., 2005), raising many questions. Does any
microRNA targeted to the HCV genome regulate viral genome
amplification? Curiously, HCV RNA can replicate in non-
hepatic cells (Zhu et al., 2003) raising the question of whether
non-hepatic microRNAs regulate viral RNA amplification in
these cells or whether the role of miR-122 in regulating HCV
gene expression occurs only in the liver. Does the microRNA
help to anchor the membrane-bound viral replication complex?
What are the natural targets for miR-122 in the liver and is
target recognition altered when HCV RNA concentration is
high in this tissue? Finally, pegylated interferon-a and ribavirin
therapy against HCV is frequently ineffective, particularly in
patients infected with genotype 1; thus, there is a need to search
for alternative antiviral targets (De Francesco and Migliaccio,
2005). Sequestration of miR-122 could provide a possible
antiviral tool against a rapidly evolving viral genome.
Defense of a retrovirus against attack by a microRNA in
mammalian cells
In contrast to HCV, a retrovirus, primate foamy virus-1 (PFV-
1), seems to have evolved an SRS function to counteract the
function of a host microRNA in mammalian cells (Lecellier etTable 1
Suppressors of RNA silencing (SRS) and their effects on double-stranded RNA ac
SRS Virus Viral family Genom
NS1 Influenza A/B/C Orthomyxovirus ssRNA
E3L Vaccinia virus Poxvirus dsDNA
B2 Nodamura virus Nodavirus ssRNA
NSs La Crosse virus Bunyavirus ssRNA
Tat HIV-1 Retrovirus ssRNA
Tas PFV-1 Retrovirus ssRNA
VA RNAs Adenovirus Adenovirus dsDNAal., 2005). In particular, it was found that microRNA miR-32
restricts the expression of PFV-1 in cultured human cells (Fig. 1).
In the presence of plant viral SRS p19 (see above), PFV-1 RNA
accumulation could be restored. The target for cellular miR-32
resides in PFV-1 open reading frame 2. MiR-32 binding reduced
viral RNA abundance and PFV-1 RNA levels could be enhanced
by introducing two point mutations into the miR-32 target
sequence. Subsequently, it was found that PFV-1 encoded Tas
protein counteracts the RNAi pathway in infected cells
(Lecellier et al., 2005) (Fig. 1), leading to a general over-
expression of microRNAs, an effect that also was observed for
the potyviral HcPro RNA silencing suppressor in plants
(Dunoyer et al., 2004). It is intriguing to speculate why PFV-1
evolved the SRS Tas function instead of simply mutating the
target sequence of miR-32 while conserving the codon
information. It is possible that this region is very conserved for
an unknown reason or, more probably, miR-32 is not the only
component of the RNA silencing machinery that PFV-1 must
counteract.
Concluding remarks
A picture is emerging in which mammalian viruses, like
those that infect plants and invertebrates, have developed
different strategies to inhibit and, in some cases, exploit the
RNA silencing machinery (Fig. 1). RNA silencing is appar-
ently used by mammals as a nucleic acid-based immunity in
addition to the dsRNA-inducible PKR pathway and protein-
based immunity. It is striking that most identified mammalian
RNA silencing suppressors also function to inhibit the PKR
pathway (Table 1). It has been hypothesized that these two
pathways act in a synergistic manner in the early phases of viral
infections, whereas protein-based innate immunity is active
several hours after infection begins (Chen et al., 2005). Perhaps
not surprisingly, certain viruses, such as SV40 and HCV, have
evolved to utilize the microRNA pathway to their own
advantages. One can only anticipate with excitement what will
be learned about the roles of microRNAs, encoded by
herpesviruses and those to be discovered in other viruses, in
virus–host interactions. Considering that microRNAs are
predicted to regulate a third of human genes, they are likely
to play prominent roles in viral life cycles as well.tivated protein kinase PKR in mammalian cells
e Comments PKR
inhibition
() SRS function shown in insect cells Yes
SRS function shown in insect cells Yes
(+) Inhibition of Dicer-mediated cleavage
by binding to dsRNA precursors
?
() Inhibition of Dicer-mediated cleavage ?
(+) Inhibition of Dicer-mediated cleavage Yes
(+) Inhibition of microRNA function, causes
unspecific accumulation of microRNAs
?
Saturation of Exportin5, Dicer and RISC Yes
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